Logo image of SABE.PA

SAINT JEAN GROUPE SA (SABE.PA) Stock Fundamental Analysis

Europe - EPA:SABE - FR0000060121 - Common Stock

19 EUR
-0.3 (-1.55%)
Last: 9/16/2025, 7:00:00 PM
Fundamental Rating

3

Overall SABE gets a fundamental rating of 3 out of 10. We evaluated SABE against 58 industry peers in the Food Products industry. The financial health of SABE is average, but there are quite some concerns on its profitability. SABE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year SABE was profitable.
In the past year SABE had a positive cash flow from operations.
In the past 5 years SABE has always been profitable.
SABE had a positive operating cash flow in each of the past 5 years.
SABE.PA Yearly Net Income VS EBIT VS OCF VS FCFSABE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

SABE has a Return On Assets of 1.21%. This is in the lower half of the industry: SABE underperforms 68.97% of its industry peers.
With a Return On Equity value of 2.64%, SABE is not doing good in the industry: 67.24% of the companies in the same industry are doing better.
SABE has a Return On Invested Capital of 0.74%. This is in the lower half of the industry: SABE underperforms 79.31% of its industry peers.
SABE had an Average Return On Invested Capital over the past 3 years of 1.23%. This is significantly below the industry average of 7.05%.
Industry RankSector Rank
ROA 1.21%
ROE 2.64%
ROIC 0.74%
ROA(3y)1.32%
ROA(5y)1.25%
ROE(3y)3.01%
ROE(5y)2.68%
ROIC(3y)1.23%
ROIC(5y)1.21%
SABE.PA Yearly ROA, ROE, ROICSABE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

With a Profit Margin value of 1.72%, SABE is not doing good in the industry: 62.07% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of SABE has declined.
Looking at the Operating Margin, with a value of 1.18%, SABE is doing worse than 79.31% of the companies in the same industry.
SABE's Operating Margin has declined in the last couple of years.
SABE has a Gross Margin (35.13%) which is in line with its industry peers.
In the last couple of years the Gross Margin of SABE has declined.
Industry RankSector Rank
OM 1.18%
PM (TTM) 1.72%
GM 35.13%
OM growth 3Y-18.97%
OM growth 5Y-12.42%
PM growth 3Y-4.9%
PM growth 5Y-18.34%
GM growth 3Y-0.46%
GM growth 5Y-1.77%
SABE.PA Yearly Profit, Operating, Gross MarginsSABE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

SABE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, SABE has about the same amount of shares outstanding.
The number of shares outstanding for SABE has been reduced compared to 5 years ago.
SABE has a better debt/assets ratio than last year.
SABE.PA Yearly Shares OutstandingSABE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
SABE.PA Yearly Total Debt VS Total AssetsSABE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

SABE has an Altman-Z score of 1.97. This is not the best score and indicates that SABE is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of SABE (1.97) is comparable to the rest of the industry.
SABE has a Debt/Equity ratio of 0.66. This is a neutral value indicating SABE is somewhat dependend on debt financing.
SABE has a Debt to Equity ratio of 0.66. This is comparable to the rest of the industry: SABE outperforms 44.83% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF N/A
Altman-Z 1.97
ROIC/WACC0.13
WACC5.78%
SABE.PA Yearly LT Debt VS Equity VS FCFSABE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

SABE has a Current Ratio of 2.04. This indicates that SABE is financially healthy and has no problem in meeting its short term obligations.
SABE has a better Current ratio (2.04) than 77.59% of its industry peers.
A Quick Ratio of 1.70 indicates that SABE should not have too much problems paying its short term obligations.
The Quick ratio of SABE (1.70) is better than 84.48% of its industry peers.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 1.7
SABE.PA Yearly Current Assets VS Current LiabilitesSABE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for SABE have decreased strongly by -52.15% in the last year.
The earnings per share for SABE have been decreasing by -11.41% on average. This is quite bad
The Revenue has been growing slightly by 1.02% in the past year.
Measured over the past years, SABE shows a small growth in Revenue. The Revenue has been growing by 7.46% on average per year.
EPS 1Y (TTM)-52.15%
EPS 3Y3.48%
EPS 5Y-11.41%
EPS Q2Q%-84.15%
Revenue 1Y (TTM)1.02%
Revenue growth 3Y7.11%
Revenue growth 5Y7.46%
Sales Q2Q%1.68%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SABE.PA Yearly Revenue VS EstimatesSABE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 30.16, SABE can be considered very expensive at the moment.
SABE's Price/Earnings ratio is a bit more expensive when compared to the industry. SABE is more expensive than 62.07% of the companies in the same industry.
SABE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.20.
Industry RankSector Rank
PE 30.16
Fwd PE N/A
SABE.PA Price Earnings VS Forward Price EarningsSABE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SABE indicates a somewhat cheap valuation: SABE is cheaper than 68.97% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.79
SABE.PA Per share dataSABE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.50%, SABE is not a good candidate for dividend investing.
SABE's Dividend Yield is slightly below the industry average, which is at 3.27.
Compared to an average S&P500 Dividend Yield of 2.38, SABE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.5%

5.2 History

The dividend of SABE decreases each year by -14.70%.
Dividend Growth(5Y)-14.7%
Div Incr Years0
Div Non Decr Years2
SABE.PA Yearly Dividends per shareSABE.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 0.05 0.1 0.15 0.2

5.3 Sustainability

SABE pays out 15.81% of its income as dividend. This is a sustainable payout ratio.
SABE's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP15.81%
EPS Next 2YN/A
EPS Next 3YN/A
SABE.PA Yearly Income VS Free CF VS DividendSABE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M
SABE.PA Dividend Payout.SABE.PA Dividend Payout, showing the Payout Ratio.SABE.PA Dividend Payout.PayoutRetained Earnings

More info and screens

SAINT JEAN GROUPE SA

EPA:SABE (9/16/2025, 7:00:00 PM)

19

-0.3 (-1.55%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners12.41%
Ins Owner ChangeN/A
Market Cap60.80M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.5%
Yearly Dividend0.1
Dividend Growth(5Y)-14.7%
DP15.81%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 30.16
Fwd PE N/A
P/S 0.52
P/FCF N/A
P/OCF 5.71
P/B 0.8
P/tB 0.87
EV/EBITDA 6.79
EPS(TTM)0.63
EY3.32%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.9
FCFYN/A
OCF(TTM)3.33
OCFY17.51%
SpS36.51
BVpS23.83
TBVpS21.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.21%
ROE 2.64%
ROCE 1.01%
ROIC 0.74%
ROICexc 0.99%
ROICexgc 1.05%
OM 1.18%
PM (TTM) 1.72%
GM 35.13%
FCFM N/A
ROA(3y)1.32%
ROA(5y)1.25%
ROE(3y)3.01%
ROE(5y)2.68%
ROIC(3y)1.23%
ROIC(5y)1.21%
ROICexc(3y)1.73%
ROICexc(5y)1.82%
ROICexgc(3y)1.85%
ROICexgc(5y)1.97%
ROCE(3y)1.67%
ROCE(5y)1.64%
ROICexcg growth 3Y-22.35%
ROICexcg growth 5Y-20.1%
ROICexc growth 3Y-21.76%
ROICexc growth 5Y-18.9%
OM growth 3Y-18.97%
OM growth 5Y-12.42%
PM growth 3Y-4.9%
PM growth 5Y-18.34%
GM growth 3Y-0.46%
GM growth 5Y-1.77%
F-Score7
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF N/A
Debt/EBITDA 3.97
Cap/Depr 120.52%
Cap/Sales 11.59%
Interest Coverage 250
Cash Conversion 84.42%
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 1.7
Altman-Z 1.97
F-Score7
WACC5.78%
ROIC/WACC0.13
Cap/Depr(3y)230.83%
Cap/Depr(5y)238.47%
Cap/Sales(3y)16.15%
Cap/Sales(5y)16.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.15%
EPS 3Y3.48%
EPS 5Y-11.41%
EPS Q2Q%-84.15%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.02%
Revenue growth 3Y7.11%
Revenue growth 5Y7.46%
Sales Q2Q%1.68%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-71.87%
EBIT growth 3Y-13.22%
EBIT growth 5Y-5.88%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.88%
OCF growth 3Y8.5%
OCF growth 5Y8.59%